Cannabis Policy and Culture

Shoppers Drug Mart moves away from medical cannabis, will transfer patients to Avicanna

Global banking crisis threatens to further squeeze funding for U.S. cannabis sector

Cannabis ‘price war’ could cause ‘significant’ damage to industry, Hexo chief executive says

Cannabis companies weigh pricing strategies after OCS margin cut

Ontario Cannabis Store to reduce price margins in bid to help shops compete with illicit market

Twitter becomes first social media platform to allow cannabis ads in U.S.

Canopy Growth’s boom and bust: A timeline

Hong Kong to ban CBD, place it in same category as heroin and fentanyl

Market movers: Stocks that saw action on Monday - and why

Cannabis company Tilray Brands reports second-quarter loss as it temporarily slows production

Cannabis-infused figs in Quebec may be delicious, but black market still thriving

New York opens its first legal recreational cannabis dispensary

The real reason why there are two marijuana stores on every block

Former CannTrust compliance worker says unlicensed growing was ‘very openly’ discussed

Legal and political uncertainties plague cannabis sector despite signs U.S. is moving closer to legalization

Canopy Growth CEO says he is hopeful for cannabis reforms after U.S. midterm elections

Former CEO of Canadian Cannabis Corp. agrees to six-year ban in OSC settlement

Canada was poised to be a leader in clinical cannabis trials. Four years in, bureaucratic red tape continues to smother progress

Cannabis producer Canopy Growth looks to grow U.S. business with new holding company structure

Canada takes the hard road at FIFA Women’s World Cup